CDRH Urges Firms To Close Loop On CAPAs, Create Filters To Weed Out Poor Quality Data
This article was originally published in The Silver Sheet
Executive Summary
Applying a closed-loop approach to corrective and preventive action activities is one of the best ways to ensure device quality and gather useful data, FDA says. Manufacturers often fail to ensure that they complete the CAPA loop, leading to corrective and preventive actions that might be open for years, or product fixes that don’t work and complicate matters further by presenting the firms with a whole new set of challenges. And, “if an FDA investigator comes to your doorstep, he or she will look at what type of data sources you are including in your CAPA system. The investigator will try to verify how you are handling that data,” CDRH Quality System Specialist Jay Jariwala says. He also advises firms to make sure enough quality data is being passed along to their CAPA systems. “Never be afraid to feed your CAPA system. Not feeding it is the worst thing you can do,” Jariwala says.
You may also be interested in...
Analysis: Foreign Firms Hit With Majority Of FDA Quality-Linked Warning Letters Last Year
Most of the 150 warning letters issued by FDA last year were sent to foreign manufacturers, a “Silver Sheet” analysis shows. That letters to overseas companies have outpaced those to domestic ones is a surprise given that the agency performs nearly four times as many inspections of U.S.-based facilities each year. But the foreign warning letter increase in 2013 might actually be a sign that FDA’s enhanced focus on overseas compliance in recent years has begun paying dividends. In related warning letter trends, CAPA has supplanted complaint handling as the No. 1 deficiency area cited in letters. Further, 56 close-out letters were sent to firms in 2013, down slightly from 2013.
Speaking Of Medtech, Ep. 10: FDA’s TAP Pilot
In this FINAL EPISODE of Speaking Of Medtech: The US FDA got something it desperately wanted in its latest user-fee package with industry: a Total Product Lifecycle Advisory Program pilot, or TAP. The agency says TAP will allow for earlier and more frequent engagement with developers – but is it needed?
Thumbs Up: FDA Authorizes Weight Loss Suturing Systems From Apollo Endosurgery
People with obesity now have new tools to help them lose weight, thanks to the US agency’s de novo authorization.